Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

1.

Instrumental variable methods for causal inference: early work and recent developments.

Baker SG.

Stat Med. 2014 Jul 30;33(17):3058-9. doi: 10.1002/sim.6168. No abstract available.

PMID:
24989339
[PubMed - in process]
2.

Principal stratification: All-or-none versus partial compliance.

Baker SG.

Clin Trials. 2014 May 20;11(3):380-381. [Epub ahead of print] No abstract available.

PMID:
24844842
[PubMed - as supplied by publisher]
3.

How to interpret a small increase in AUC with an additional risk prediction marker: decision analysis comes through.

Baker SG, Schuit E, Steyerberg EW, Pencina MJ, Vickers A, Moons KG, Mol BW, Lindeman KS.

Stat Med. 2014 May 13. doi: 10.1002/sim.6195. [Epub ahead of print]

PMID:
24825728
[PubMed - as supplied by publisher]
4.

The randomized registry trial.

Baker SG, Kramer BS, Lindeman KS.

N Engl J Med. 2014 Feb 13;370(7):681-2. doi: 10.1056/NEJMc1315677. No abstract available.

PMID:
24521130
[PubMed - indexed for MEDLINE]
Free Article
5.

Letter to the editor: "Comment on Hubbard and Miglioretti (2013), consider also a selection model for the cumulative risk of false positive screening tests".

Baker SG.

Biometrics. 2013 Dec;69(4):1084. doi: 10.1111/biom.12116. No abstract available.

PMID:
24328716
[PubMed - in process]
6.

Causal inference, probability theory, and graphical insights.

Baker SG.

Stat Med. 2013 May 10. doi: 10.1002/sim.5828. [Epub ahead of print]

PMID:
23661231
[PubMed - as supplied by publisher]
7.

The risky reliance on small surrogate endpoint studies when planning a large prevention trial.

Baker SG, Kramer BS.

J R Stat Soc Ser A Stat Soc. 2013 Feb 1;176(2):603-608. Epub 2012 Jun 28.

PMID:
23565041
[PubMed]
Free PMC Article
8.

Combination antifungal therapy for cryptococcal meningitis.

Day JN, Chau TT, Wolbers M, Mai PP, Dung NT, Mai NH, Phu NH, Nghia HD, Phong ND, Thai CQ, Thai le H, Chuong LV, Sinh DX, Duong VA, Hoang TN, Diep PT, Campbell JI, Sieu TP, Baker SG, Chau NV, Hien TT, Lalloo DG, Farrar JJ.

N Engl J Med. 2013 Apr 4;368(14):1291-302. doi: 10.1056/NEJMoa1110404.

PMID:
23550668
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Remarks on 'A simple decision analytic solution to the comparison of two binary diagnostic tests' by Vickers et al.

Baker SG.

Stat Med. 2013 Feb 20;32(4):718. doi: 10.1002/sim.5663. No abstract available.

PMID:
23341085
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Evaluation of markers and risk prediction models: overview of relationships between NRI and decision-analytic measures.

Van Calster B, Vickers AJ, Pencina MJ, Baker SG, Timmerman D, Steyerberg EW.

Med Decis Making. 2013 May;33(4):490-501. doi: 10.1177/0272989X12470757. Epub 2013 Jan 11. Review.

PMID:
23313931
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Surrogate endpoint analysis: an exercise in extrapolation.

Baker SG, Kramer BS.

J Natl Cancer Inst. 2013 Mar 6;105(5):316-20. doi: 10.1093/jnci/djs527. Epub 2012 Dec 21.

PMID:
23264679
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Clonality despite sex: the evolution of host-associated sexual neighborhoods in the pathogenic fungus Penicillium marneffei.

Henk DA, Shahar-Golan R, Devi KR, Boyce KJ, Zhan N, Fedorova ND, Nierman WC, Hsueh PR, Yuen KY, Sieu TP, Kinh NV, Wertheim H, Baker SG, Day JN, Vanittanakom N, Bignell EM, Andrianopoulos A, Fisher MC.

PLoS Pathog. 2012;8(10):e1002851. doi: 10.1371/journal.ppat.1002851. Epub 2012 Oct 4.

PMID:
23055919
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Evaluating a new marker for risk prediction: decision analysis to the rescue.

Baker SG, Kramer BS.

Discov Med. 2012 Sep;14(76):181-8. Review.

PMID:
23021372
[PubMed - indexed for MEDLINE]
Free Article
14.

Comment on Nie et al. (2011), biometrics, early view.

Baker SG.

Biometrics. 2012 Sep;68(3):992; author reply 992. doi: 10.1111/j.1541-0420.2012.01802.x. No abstract available.

PMID:
23013226
[PubMed - indexed for MEDLINE]
15.

Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study.

Raji OY, Duffy SW, Agbaje OF, Baker SG, Christiani DC, Cassidy A, Field JK.

Ann Intern Med. 2012 Aug 21;157(4):242-50. doi: 10.7326/0003-4819-157-4-201208210-00004.

PMID:
22910935
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Evaluating a new marker for risk prediction using the test tradeoff: an update.

Baker SG, Van Calster B, Steyerberg EW.

Int J Biostat. 2012 Mar 22;8(1). pii: /j/ijb.2012.8.issue-1/1557-4679.1395/1557-4679.1395.xml. doi: 10.1515/1557-4679.1395.

PMID:
22499728
[PubMed - indexed for MEDLINE]
17.

Biomarkers, subgroup evaluation, and clinical trial design.

Baker SG, Kramer BS, Sargent DJ, Bonetti M.

Discov Med. 2012 Mar;13(70):187-92. Review.

PMID:
22463794
[PubMed - indexed for MEDLINE]
Free Article
18.

Gene signatures revisited.

Baker SG.

J Natl Cancer Inst. 2012 Feb 22;104(4):262-3. doi: 10.1093/jnci/djr557. Epub 2012 Jan 18. No abstract available.

PMID:
22262869
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Capecitabine-induced hand-foot syndrome complicated by pseudomonal superinfection resulting in bacterial sepsis and death: case report and review of the literature.

Hoesly FJ, Baker SG, Gunawardane ND, Cotliar JA.

Arch Dermatol. 2011 Dec;147(12):1418-23. doi: 10.1001/archdermatol.2011.320. Review.

PMID:
22184763
[PubMed - indexed for MEDLINE]
20.

TOFT better explains experimental results in cancer research than SMT (comment on DOI 10.1002/bies.201100025 and DOI 10.1002/bies.201100022).

Baker SG.

Bioessays. 2011 Dec;33(12):919-21. doi: 10.1002/bies.201100124. Epub 2011 Oct 14. No abstract available.

PMID:
21997327
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk